The Addition Study

The ADDITION* study is a multi-factorial intervention study which primarily focuses on cardiovascular morbidity and mortality among people with screen detected type-2 diabetes in UK, the Netherlands and Denmark.

The target population for the screening program was close to 400.000 people aged 40-69 years. The screening program differed between countries and formed different at risk groups with impaired fasting blood glucose, impaired glucose tolerance or increased cardiovascular disease risk without dysglycemia.  

Where possible analyses have been done for all 3 countries under the acronym: 

ADDITION-EUROPE

Where common analyses were not obvious analysis have been done for separate centres under the following acronyms:

ADDITION-Cambridge

ADDITION-Leicester

ADDITION-Netherlands

ADDITION-Denmark
   -ADDITION-PRO

* Anglo-Danish-Dutch Study of Intensive Treatment In People with Screen Detected Diabetes in Primary Care.